Pan Drugs Limited, a active public limited company, was established on 16 November 1993 in Vadodara, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230GJ1993PLC020671. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹5.50 Cr and a paid-up capital of ₹3.14 Cr.
It upholds a compliant status. Employing 34 professional, Its leadership includes Atul Natwarlal Pandya (Director), Parag Vamanray Raval (Director), Kamal Natwarlal Pandya (Director). Past directors included Sudhirkumar Anantprakash Dhingra, Atul Natwarlal Pandya, Kashmira Atulbhai Pandya. It holds ₹2.84 M open charges and ₹45.08 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 301,312 World Trade Center, Sayajigunj, Vadodara, Gujarat, 390007.
U24230GJ1993PLC020671
020671
16 November 1993
₹5.50 Cr
₹3.14 Cr
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Pan Drugs Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Atul Natwarlal Pandya | Director | 31 Jul 2007 | Current |
| Parag Vamanray Raval | Director | 10 May 2018 | Current |
| Kamal Natwarlal Pandya | Director | 16 Nov 1993 | Current |
| Hemant Gajanand Upadhyay | Director | 31 May 2003 | Current |
| Rushiraj Atulbhai Pandya | Additional Director | 10 Mar 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 26 Jul 2015 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2007 | Past |
| Pramod Abcsdd | Director | 23 Feb 2018 | Past |
| Pramod Abcsdd | Cfo(Kmp) | - | Past |
| Pramod Abcsdd | Director | 24 Feb 2018 | Past |
| Pramod Abcsdd | Director | 24 Feb 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Pan Drugs Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 18.99% decrease. The company also saw a substantial improvement in profitability, with a 2162.05% increase in profit. The company's net worth Soared by an impressive increase of 191.08%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Pan Drugs had a promoter holding of 43.56% and a public holding of 56.44%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹2,842,702.00
₹450,800,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Dec 2021 | Hdfc Bank Limited | ₹2.84 M | Open |
| 20 Oct 2001 | State Band Of Hydrabad | ₹3.00 Cr | Satisfied |
| 13 Sep 2000 | Anyonya Co - Operative Bank Ltd. | ₹1.00 Cr | Satisfied |
| 31 Mar 2000 | Idbi Bank Ltd. | ₹11.00 Cr | Satisfied |
| 03 Dec 1999 | Idbi Bank Ltd. | ₹8.50 Cr | Satisfied |
Explore comprehensive loan charge details -
Pan Drugs has a workforce of 34 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Pan Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pan Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Rushiraj Atulbhai Pandya was appointed as a Additional Director was appointed as a Additional Director on 10 Mar 2025 & has been associated with this company since 8 months 22 days . was recorded as a recent event.
Progress on Pan Drugs Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Pan Drugs Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was completed.
A charge with Hdfc Bank Limited amounted to Rs. 0.28 Cr with Charge ID 100527683 was registered on 31 Dec 2021. was recorded as a recent event.
A charge registered on 13 Sep 2000 via Charge ID 90099257 with Anyonya Co - Operative Bank Ltd. was fully satisfied on 23 Jan 2020. was recorded as a recent event.
A charge registered on 15 Oct 1998 via Charge ID 90096565 with Anyonya Sahakari Mandli Co - Op. Bank Ltd. was fully satisfied on 23 Jan 2020. was recorded as a recent event.
The CIN of Pan Drugs Limited is U24230GJ1993PLC020671.
Pan Drugs Limited is headquartered at 301,312 World Trade Center, Sayajigunj, Vadodara, Gujarat, 390007.
Pan Drugs Limited was incorporated on 16 November 1993.
The current directors of Pan Drugs Limited are
The primary industry of Pan Drugs Limited is Manufacturing.
Pan Drugs Limited is unlisted.
The authorized capital of Pan Drugs Limited is ₹5.50 Cr, and the paid-up capital is ₹3.14 Cr.
The compliance status of Pan Drugs Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX